Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Aldeyra Therapeutics Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-08-09
Purchase
2022-08-11
4:08 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
115,000 $7.5457 $867,750 11,350,085
(Indirect)
View
2022-08-08
Purchase
2022-08-10
4:10 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
97,000 $7.24 $702,280 11,235,085
(Indirect)
View
2022-08-05
Purchase
2022-08-09
4:08 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
141,000 $6.95 $979,950 11,138,085
(Indirect)
View
2022-08-04
Purchase
2022-08-08
4:09 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
95,100 $6.17 $586,767 10,997,085
(Indirect)
View
2022-08-03
Purchase
2022-08-05
4:10 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
100,000 $5.84 $584,000 10,901,985
(Indirect)
View
2022-08-02
Purchase
2022-08-04
4:10 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
412,406 $5.59 $2,305,350 10,801,985
(Indirect)
View
2022-08-01
Purchase
2022-08-03
5:16 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
144,185 $5.05 $728,134 10,389,579
(Indirect)
View
2022-07-29
Purchase
2022-08-02
4:27 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
222,123 $5.03 $1,117,279 10,245,394
(Indirect)
View
2022-07-28
Purchase
2022-08-01
5:37 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
119,392 $5 $596,960 10,023,271
(Indirect)
View
2022-06-23
Purchase
2022-06-27
06:42 am
Aldeyra Therapeutics Inc. ALDX JOYCE MARTIN JOSEPH
Director
4,323 $3.4755 $15,025 23,967
(Direct)
View
2022-06-23
Purchase
2022-06-27
06:41 am
Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO
17,700 $3.3642 $59,546 1,216,535
(Direct)
View
2021-05-03
Purchase
2021-05-04
5:55 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
1,200,000 $12.5 $15,000,000 9,903,879
(Indirect)
View
2021-01-19
Purchase
2021-01-21
5:24 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
1,368,421 $9.5 $13,000,000 8,703,879
(Indirect)
View
2021-01-07
Purchase
2021-01-11
9:53 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
1,050,000 $8.7644 $9,202,668 7,335,458
(Indirect)
View
2020-07-09
Purchase
2020-07-13
4:30 pm
Aldeyra Therapeutics Inc. ALDX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
3,200,000 $4.25 $13,600,000 6,285,458
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-07-15
Option Award
2022-07-19
4:34 pm
N/A
N/A
Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO
604,308 $0 604,308
(Direct)
View
2022-07-15
Option Award
2022-07-19
4:34 pm
N/A
N/A
Aldeyra Therapeutics Inc. ALDX Greenberg Bruce
See Remarks
126,087 $0 133,900
(Direct)
View
2022-07-15
Option Award
2022-07-19
4:34 pm
N/A
N/A
Aldeyra Therapeutics Inc. ALDX Machatha Stephen
Chief Development Officer
255,078 $0 342,947
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:07 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc. ALDX JOYCE MARTIN JOSEPH
Director
62,394 $0 62,394
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:07 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc. ALDX Miller-Rich Nancy
Director
56,131 $0 56,131
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:06 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc. ALDX Phillips Gary M.
Director
61,930 $0 61,930
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:06 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc. ALDX Bronstein Ben
Director
61,002 $0 61,002
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:06 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc. ALDX DOUGLAS RICHARD
Director
69,353 $0 69,353
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:04 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc. ALDX Walker Neal
Director
56,131 $0 56,131
(Direct)
View
2022-05-10
Ownership
2022-05-13
4:28 pm
N/A
N/A
Aldeyra Therapeutics Inc. ALDX Greenberg Bruce
See Remarks
0 $0 333,685
(Direct)
View
2022-03-30
Option Award
2022-04-01
7:44 pm
N/A
2032-03-29
Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO
457,758 $0 1,656,593
(Direct)
View
2022-03-30
Option Award
2022-04-01
7:37 pm
N/A
2032-03-29
Aldeyra Therapeutics Inc. ALDX Reed Joshua
CFO
343,322 $0 524,825
(Direct)
View
2022-03-30
Option Award
2022-04-01
7:37 pm
N/A
2032-03-29
Aldeyra Therapeutics Inc. ALDX Machatha Stephen
Chief Development Officer
314,395 $0 337,869
(Direct)
View
2021-06-08
Option Award
2021-06-10
5:46 pm
N/A
2031-06-07
Aldeyra Therapeutics Inc. ALDX DOUGLAS RICHARD
Director
17,442 $0 17,442
(Direct)
View
2021-06-08
Option Award
2021-06-10
5:46 pm
N/A
2031-06-07
Aldeyra Therapeutics Inc. ALDX Phillips Gary M.
Director
15,576 $0 15,576
(Direct)
View
2021-06-08
Option Award
2021-06-10
5:46 pm
N/A
2031-06-07
Aldeyra Therapeutics Inc. ALDX Miller-Rich Nancy
Director
14,117 $0 14,117
(Direct)
View
2021-06-08
Option Award
2021-06-10
5:45 pm
N/A
2031-06-07
Aldeyra Therapeutics Inc. ALDX JOYCE MARTIN JOSEPH
Director
15,692 $0 15,692
(Direct)
View
2021-06-08
Option Award
2021-06-10
5:45 pm
N/A
2031-06-07
Aldeyra Therapeutics Inc. ALDX Walker Neal
Director
14,117 $0 14,117
(Direct)
View
2021-06-08
Option Award
2021-06-10
5:44 pm
N/A
2031-06-07
Aldeyra Therapeutics Inc. ALDX Bronstein Ben
Director
15,342 $0 15,342
(Direct)
View
2021-04-12
Option Award
2021-04-14
7:25 pm
N/A
2031-04-11
Aldeyra Therapeutics Inc. ALDX Reed Joshua
CFO
150,185 $0 150,185
(Direct)
View
2021-04-12
Option Award
2021-04-14
7:24 pm
N/A
2031-04-11
Aldeyra Therapeutics Inc. ALDX Machatha Stephen
Chief Development Officer
116,201 $0 116,201
(Direct)
View
2021-04-12
Option Award
2021-04-14
7:23 pm
N/A
2031-04-11
Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO
296,619 $0 1,198,835
(Direct)
View
2020-12-08
Ownership
2020-12-18
6:06 pm
N/A
N/A
Aldeyra Therapeutics Inc. ALDX Machatha Stephen
Chief Development Officer
0 $0 325,635
(Direct)
View
2020-06-09
Option Award
2020-06-11
5:51 pm
N/A
2030-06-08
Aldeyra Therapeutics Inc. ALDX Bronstein Ben
Director
30,355 $0 30,355
(Direct)
View
2020-06-09
Option Award
2020-06-11
5:48 pm
N/A
2030-06-08
Aldeyra Therapeutics Inc. ALDX Miller-Rich Nancy
Director
26,503 $0 26,503
(Direct)
View
Goto 0, 1, 2, Next